Nyrada (ASX:NYR) collaboration with Walter Reed and UNSW

Published: Feb. 3, 2021, 5:15 a.m.

03 February 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar talks about the company's collaboration agreement with the Walter Reed Army Institute of Research and UNSW into the study of a first-ever pharmaceutical treatment for traumatic brain injury, a top health priority for the military.